Subsidiary Secured Valuation Worth Nearly 20X Of Parent Company's Market Cap

Retrieved on: 2021-06-22 19:07:30

Tags for this article:

Valuation

Drug delivery

nugenerex immuno-oncology

Generex Biotechnology Corp.

Click the tags to see associated articles and topics

Subsidiary Secured Valuation Worth Nearly 20X Of Parent Company's Market Cap. View article details on hiswai:

Excerpt

A Florida-based biotech company just announced that its subsidiary ... Shares of parent company Generex Biotechnology Corp (OTCQB:GNBT) ripped ... its subsidiaries that work by stimulating the immune system to either attack ...

Article found on: www.baystreet.ca

View Original Article